The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research

Cell Metabolism

Volumn 23, Issue 6, 2016, Pages 980-989

  Milman, Sofiya ^a   Huffman, Derek M ^a   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

AGING; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CEREBROVASCULAR ACCIDENT; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC VARIATION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; LIFESPAN; LUNG CANCER; METASTATIC MELANOMA; MILD COGNITIVE IMPAIRMENT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; DISEASES; METABOLISM; RESEARCH; SIGNAL TRANSDUCTION;

AGING; DISEASE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RESEARCH; SIGNAL TRANSDUCTION;

EID: 84975451703     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.05.014     Document Type: Review

References (117)

1. A. Abbas, H. Imrie, H. Viswambharan, P. Sukumar, A. Rajwani, R.M. Cubbon, M. Gage, J. Smith, S. Galloway, N. Yuldeshava, and et al. The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium Diabetes 60 2011 2169 2178
2. W.K. Al-Delaimy, D. von Muhlen, and E. Barrett-Connor Insulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and women J. Am. Geriatr. Soc. 57 2009 1441 1446
3. K.A. Al-Regaiey, M.M. Masternak, M. Bonkowski, L. Sun, and A. Bartke Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction Endocrinology 146 2005 851 860
4. S.L. Andersen, P. Sebastiani, D.A. Dworkis, L. Feldman, and T.T. Perls Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 395 405
5. M. Andreassen, I. Raymond, C. Kistorp, P. Hildebrandt, J. Faber, and L.O. Kristensen IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population Eur. J. Endocrinol. 160 2009 25 31
6. M. Anzo, L.J. Cobb, D.L. Hwang, H. Mehta, J.W. Said, S. Yakar, D. LeRoith, and P. Cohen Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression Cancer Res. 68 2008 3342 3349
7. N.M. Ashpole, J.E. Sanders, E.L. Hodges, H. Yan, and W.E. Sonntag Growth hormone, insulin-like growth factor-1 and the aging brain Exp. Gerontol. 68 2015 76 81
8. N.M. Ashpole, J.C. Herron, P.N. Estep, S. Logan, E.L. Hodges, A. Yabluchanskiy, M.B. Humphrey, and W.E. Sonntag Differential effects of IGF-1 deficiency during the life span on structural and biomechanical properties in the tibia of aged mice Age (Dordr.) 38 2016 38
9. L.C. Bailey-Downs, M. Mitschelen, D. Sosnowska, P. Toth, J.T. Pinto, P. Ballabh, M.N. Valcarcel-Ares, J. Farley, A. Koller, J.C. Henthorn, and et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 313 329
10. E.M. Bailyes, B.T. Navé, M.A. Soos, S.R. Orr, A.C. Hayward, and K. Siddle Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting Biochem. J. 327 1997 209 215
11. A. Bansal, L.J. Zhu, K. Yen, and H.A. Tissenbaum Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants Proc. Natl. Acad. Sci. USA 112 2015 E277 E286
12. R.C. Baxter Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am. J. Physiol. Endocrinol. Metab. 278 2000 E967 E976
13. D. Bergman, M. Halje, M. Nordin, and W. Engström Insulin-like growth factor 2 in development and disease: a mini-review Gerontology 59 2013 240 249
14. C.L. Boguszewski, and J. Ayuk Management of endocrine disease: Acromegaly and Cancer: an old debate revisited Eur. J. Endocrinol. 2016 10.1530/EJE-16-0178 Published online April 18, 2016
15. A.F. Bokov, N. Garg, Y. Ikeno, S. Thakur, N. Musi, R.A. DeFronzo, N. Zhang, R.C. Erickson, J. Gelfond, G.B. Hubbard, and et al. Does reduced IGF-1R signaling in Igf1r+/- mice alter aging? PLoS ONE 6 2011 e26891
16. E. Bollano, E. Omerovic, M. Bohlooly-y, V. Kujacic, B. Madhu, J. Törnell, O. Isaksson, B. Soussi, W. Schulze, M.L. Fu, and et al. Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene Endocrinology 141 2000 2229 2235
17. C.R. Breese, R.L. Ingram, and W.E. Sonntag Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins J. Gerontol. 46 1991 B180 B187
18. H.M. Brown-Borg, K.E. Borg, C.J. Meliska, and A. Bartke Dwarf mice and the ageing process Nature 384 1996 33
19. A.M. Burgers, N.R. Biermasz, J.W. Schoones, A.M. Pereira, A.G. Renehan, M. Zwahlen, M. Egger, and O.M. Dekkers Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality J. Clin. Endocrinol. Metab. 96 2011 2912 2920
20. A.B. Byrne, T. Walradt, K.E. Gardner, A. Hubbert, V. Reinke, and M. Hammarlund Insulin/IGF1 signaling inhibits age-dependent axon regeneration Neuron 81 2014 561 573
21. H. Cao, G. Wang, L. Meng, H. Shen, Z. Feng, Q. Liu, and J. Du Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis PLoS ONE 7 2012 e49884
22. Y. Cao, K. Nimptsch, I.M. Shui, E.A. Platz, K. Wu, M.N. Pollak, S.A. Kenfield, M.J. Stampfer, and E.L. Giovannucci Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer Int. J. Cancer 136 2015 2418 2426
23. G.P. Ceda, A.R. Hoffman, G.D. Silverberg, D.M. Wilson, and R.G. Rosenfeld Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin J. Clin. Endocrinol. Metab. 60 1985 1204 1209
24. Z. Chaker, S. Aïd, H. Berry, and M. Holzenberger Suppression of IGF-I signals in neural stem cells enhances neurogenesis and olfactory function during aging Aging Cell 14 2015 847 856
25. L.J. Cobb, H. Mehta, and P. Cohen Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation Mol. Endocrinol. 23 2009 1624 1633
26. A. Csiszar, N. Labinskyy, V. Perez, F.A. Recchia, A. Podlutsky, P. Mukhopadhyay, G. Losonczy, P. Pacher, S.N. Austad, A. Bartke, and Z. Ungvari Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice Am. J. Physiol. Heart Circ. Physiol. 295 2008 H1882 H1894
27. T. Doi, H. Shimada, H. Makizako, K. Tsutsumimoto, R. Hotta, S. Nakakubo, and T. Suzuki Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed Neurobiol. Aging 36 2015 942 947
28. E. Egecioglu, I.J. Andersson, E. Bollano, V. Palsdottir, B.G. Gabrielsson, J.J. Kopchick, O. Skott, P. Bie, J. Isgaard, M. Bohlooly-Y, and et al. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function Am. J. Physiol. Endocrinol. Metab. 292 2007 E1418 E1425
29. C.D. Fahrenholtz, P.J. Beltran, and K.L. Burnstein Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts Mol. Cancer Ther. 12 2013 394 404
30. A.M. Fernandez, and I. Torres-Alemán The many faces of insulin-like peptide signalling in the brain Nat. Rev. Neurosci. 13 2012 225 239
31. L. Fontana, D.T. Villareal, S.K. Das, S.R. Smith, S.N. Meydani, A.G. Pittas, S. Klein, M. Bhapkar, J. Rochon, E. Ravussin, J.O. Holloszy CALERIE Study Group Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial Aging Cell 15 2016 22 27
32. A.L. Friedlander, G.E. Butterfield, S. Moynihan, J. Grillo, M. Pollack, L. Holloway, L. Friedman, J. Yesavage, D. Matthias, S. Lee, and et al. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women J. Clin. Endocrinol. Metab. 86 2001 1496 1503
33. N. Friedrich, R. Haring, M. Nauck, J. Lüdemann, D. Rosskopf, E. Spilcke-Liss, S.B. Felix, M. Dörr, G. Brabant, H. Völzke, and H. Wallaschofski Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations J. Clin. Endocrinol. Metab. 94 2009 1732 1739
34. C.S. Fuchs, S. Azevedo, T. Okusaka, J.L. Van Laethem, L.R. Lipton, H. Riess, C. Szczylik, M.J. Moore, M. Peeters, G. Bodoky, and et al. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial Ann. Oncol. 26 2015 921 927
35. C. Galet, A. Gray, J.W. Said, B. Castor, J. Wan, P.J. Beltran, F.J. Calzone, D. Elashoff, P. Cohen, and W.J. Aronson Effects of calorie restriction and IGF-1 receptor blockade on the progression of 22Rv1 prostate cancer xenografts Int. J. Mol. Sci. 14 2013 13782 13795
36. S. Gombar, H.J. Jung, F. Dong, B. Calder, G. Atzmon, N. Barzilai, X.L. Tian, J. Pothof, J.H. Hoeijmakers, J. Campisi, and et al. Comprehensive microRNA profiling in B-cells of human centenarians by massively parallel sequencing BMC Genomics 13 2012 353
37. Z. Gong, O. Kennedy, H. Sun, Y. Wu, G.A. Williams, L. Klein, L. Cardoso, R.W. Matheny Jr., G.B. Hubbard, Y. Ikeno, and et al. Reductions in serum IGF-1 during aging impair health span Aging Cell 13 2014 408 418
38. G. Gontier, C. George, Z. Chaker, M. Holzenberger, and S. Aïd Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance J. Neurosci. 35 2015 11500 11513
39. C.J. Green, J.M. Holly, A. Bayer, M. Fish, S. Ebrahim, J. Gallacher, and Y. Ben-Shlomo The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: the Caerphilly Prospective Study J. Alzheimers Dis. 41 2014 867 875
40. J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, M. Wei, F. Madia, C.W. Cheng, D. Hwang, A. Martin-Montalvo, J. Saavedra, S. Ingles, and et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans Sci. Transl. Med. 3 2011 70ra13
41. M. Haluzik, S. Yakar, O. Gavrilova, J. Setser, Y. Boisclair, and D. LeRoith Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance Diabetes 52 2003 2483 2489
42. M. Hawkins, N. Barzilai, W. Chen, I. Angelov, M. Hu, P. Cohen, and L. Rossetti Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal Diabetes 45 1996 1734 1743
43. Y.H. He, X. Lu, L.Q. Yang, L.Y. Xu, and Q.P. Kong Association of the insulin-like growth factor binding protein 3 (IGFBP-3) polymorphism with longevity in Chinese nonagenarians and centenarians Aging (Albany, N.Y.) 6 2014 944 956
44. Y. Higashi, S. Sukhanov, A. Anwar, S.Y. Shai, and P. Delafontaine Aging, atherosclerosis, and IGF-1 J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 626 639
45. J.M. Holly, and C.M. Perks Insulin-like growth factor physiology: what we have learned from human studies Endocrinol. Metab. Clin. North Am. 41 2012 249 263, v
46. M. Holzenberger, J. Dupont, B. Ducos, P. Leneuve, A. Géloën, P.C. Even, P. Cervera, and Y. Le Bouc IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice Nature 421 2003 182 187
47. D.M. Huffman, M.S. Johnson, A. Watts, A. Elgavish, I.A. Eltoum, and T.R. Nagy Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake Cancer Res. 67 2007 417 424
48. D.M. Huffman, G. Farias Quipildor, K. Mao, X. Zhang, J. Wan, P. Apontes, P. Cohen, and N. Barzilai Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline Aging Cell 15 2016 181 186
49. S.D. Hursting, B.R. Switzer, J.E. French, and F.W. Kari The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats Cancer Res. 53 1993 2750 2757
50. Y. Ikeno, R.T. Bronson, G.B. Hubbard, S. Lee, and A. Bartke Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity J. Gerontol. A Biol. Sci. Med. Sci. 58 2003 291 296
51. J.A. Janssen, H. Burger, R.P. Stolk, D.E. Grobbee, F.H. de Jong, S.W. Lamberts, and H.A. Pols Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women Eur. J. Endocrinol. 138 1998 627 632
52. A. Jara, X. Liu, D. Sim, C.M. Benner, S. Duran-Ortiz, Y. Qian, E.O. List, D.E. Berryman, J.K. Kim, and J.J. Kopchick Cardiac-Specific Disruption of GH Receptor Alters Glucose Homeostasis While Maintaining Normal Cardiac Performance in Adult Male Mice Endocrinology 157 2016 1929 1941
53. A. Juul, T. Scheike, M. Davidsen, J. Gyllenborg, and T. Jørgensen Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study Circulation 106 2002 939 944
54. R.C. Kaplan, A.P. McGinn, M.N. Pollak, L.H. Kuller, H.D. Strickler, T.E. Rohan, A.R. Cappola, X. Xue, and B.M. Psaty Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke J. Clin. Endocrinol. Metab. 92 2007 1319 1325
55. R.C. Kaplan, P. Bùzková, A.R. Cappola, H.D. Strickler, A.P. McGinn, L.D. Mercer, A.M. Arnold, M.N. Pollak, and A.B. Newman Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study J. Clin. Endocrinol. Metab. 97 2012 1970 1976
56. C. Kenyon, J. Chang, E. Gensch, A. Rudner, and R. Tabtiang A C. Elegans mutant that lives twice as long as wild type Nature 366 1993 461 464
57. T.J. Key, P.N. Appleby, G.K. Reeves, A.W. Roddam Endogenous Hormones and Breast Cancer Collaborative Group Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies Lancet Oncol. 11 2010 530 542
58. H.S. Kim, O. Ali, M. Shim, K.W. Lee, P. Vuguin, R. Muzumdar, N. Barzilai, and P. Cohen Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo Pediatr. Res. 61 2007 159 164
59. J.H. Kranzler, A.L. Rosenbloom, V. Martinez, and J. Guevara-Aguirre Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population J. Clin. Endocrinol. Metab. 83 1998 1953 1958
60. J.A. Langlois, C.J. Rosen, M. Visser, M.T. Hannan, T. Harris, P.W. Wilson, and D.P. Kiel Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study J. Clin. Endocrinol. Metab. 83 1998 4257 4262
61. G.A. Laughlin, E. Barrett-Connor, M.H. Criqui, and D. Kritz-Silverstein The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study J. Clin. Endocrinol. Metab. 89 2004 114 120
62. K.C. Leung, N. Doyle, M. Ballesteros, M.J. Waters, and K.K. Ho Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation J. Clin. Endocrinol. Metab. 85 2000 4712 4720
63. M.E. Levine, J.A. Suarez, S. Brandhorst, P. Balasubramanian, C.W. Cheng, F. Madia, L. Fontana, M.G. Mirisola, J. Guevara-Aguirre, J. Wan, and et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population Cell Metab. 19 2014 407 417
64. Q. Li, A.F. Ceylan-Isik, J. Li, and J. Ren Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction Rejuvenation Res. 11 2008 725 733
65. R.J. Lichtenwalner, M.E. Forbes, S.A. Bennett, C.D. Lynch, W.E. Sonntag, and D.R. Riddle Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis Neuroscience 107 2001 603 613
66. E.O. List, D.E. Berryman, Y. Ikeno, G.B. Hubbard, K. Funk, R. Comisford, J.A. Young, M.B. Stout, T. Tchkonia, M.M. Masternak, and et al. Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice Aging (Albany, N.Y.) 7 2015 500 512
67. W. Liu, P. Ye, J.R. O'Kusky, and A.J. D'Ercole Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus J. Neurosci. Res. 87 2009 2821 2832
68. Z. Liu, S. Mohan, and S. Yakar Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies Growth Horm. IGF Res. 27 2016 7 17
69. R. López-Velasco, H.F. Escobar-Morreale, B. Vega, E. Villa, J.M. Sancho, J.L. Moya-Mur, and R. García-Robles Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? J. Clin. Endocrinol. Metab. 82 1997 1047 1053
70. M. Maggio, F. Lauretani, G.P. Ceda, S. Bandinelli, S.M. Ling, E.J. Metter, A. Artoni, L. Carassale, A. Cazzato, G. Ceresini, and et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study Arch. Intern. Med. 167 2007 2249 2254
71. S. Milman, G. Atzmon, D.M. Huffman, J. Wan, J.P. Crandall, P. Cohen, and N. Barzilai Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity Aging Cell 13 2014 769 771
72. S. Moellendorf, C. Kessels, L. Peiseler, A. Raupach, C. Jacoby, N. Vogt, A. Lindecke, L. Koch, J. Brüning, J. Heger, and et al. IGF-IR signaling attenuates the age-related decline of diastolic cardiac function Am. J. Physiol. Endocrinol. Metab. 303 2012 E213 E222
73. A.P. Muller, A.M. Fernandez, C. Haas, E. Zimmer, L.V. Portela, and I. Torres-Aleman Reduced brain insulin-like growth factor I function during aging Mol. Cell. Neurosci. 49 2012 9 12
74. R.H. Muzumdar, X. Ma, S. Fishman, X. Yang, G. Atzmon, P. Vuguin, F.H. Einstein, D. Hwang, P. Cohen, and N. Barzilai Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action Diabetes 55 2006 2788 2796
75. R. Novosyadlyy, and D. Leroith Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 640 651
76. C. Ohlsson, D. Mellström, D. Carlzon, E. Orwoll, O. Ljunggren, M.K. Karlsson, and L. Vandenput Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study J. Bone Miner. Res. 26 2011 865 872
77. O. Okereke, J.H. Kang, J. Ma, S.E. Hankinson, M.N. Pollak, and F. Grodstein Plasma IGF-I levels and cognitive performance in older women Neurobiol. Aging 28 2007 135 142
78. L. Pawlikowska, D. Hu, S. Huntsman, A. Sung, C. Chu, J. Chen, A.H. Joyner, N.J. Schork, W.C. Hsueh, A.P. Reiner, et al. Study of Osteoporotic Fractures Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity Aging Cell 8 2009 460 472
79. C. Posaci, S. Altunyurt, H. Islekel, and A. Onvural Effects of HRT on serum levels of IGF-I in postmenopausal women Maturitas 40 2001 69 74
80. S. Rajaram, D.J. Baylink, and S. Mohan Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions Endocr. Rev. 18 1997 801 831
81. S.N. Rajpathak, M. He, Q. Sun, R.C. Kaplan, R. Muzumdar, T.E. Rohan, M.J. Gunter, M. Pollak, M. Kim, J.E. Pessin, and et al. Insulin-like growth factor axis and risk of type 2 diabetes in women Diabetes 61 2012 2248 2254
82. B.S. Reddy, C.X. Wang, and H. Maruyama Effect of restricted caloric intake on azoxymethane-induced colon tumor incidence in male F344 rats Cancer Res. 47 1987 1226 1228
83. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353
84. S.L. Ricketts, K.L. Rensing, J.M. Holly, L. Chen, E.H. Young, R. Luben, S. Ashford, K. Song, X. Yuan, A. Dehghan, et al. GEMS Investigators Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease Int. J. Mol. Epidemiol. Genet. 2 2011 261 285
85. S. Rinaldi, R. Cleveland, T. Norat, C. Biessy, S. Rohrmann, J. Linseisen, H. Boeing, T. Pischon, S. Panico, C. Agnoli, and et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies Int. J. Cancer 126 2010 1702 1715
86. J.F. Robertson, J.M. Ferrero, H. Bourgeois, H. Kennecke, R.H. de Boer, W. Jacot, J. McGreivy, S. Suzuki, M. Zhu, I. McCaffery, and et al. Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial Lancet Oncol. 14 2013 228 235
87. R. Roubenoff, H. Parise, H.A. Payette, L.W. Abad, R. D'Agostino, P.F. Jacques, P.W. Wilson, C.A. Dinarello, and T.B. Harris Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study Am. J. Med. 115 2003 429 435
88. M.A. Rowlands, D. Gunnell, R. Harris, L.J. Vatten, J.M. Holly, and R.M. Martin Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis Int. J. Cancer 124 2009 2416 2429
89. D. Rudman, M.H. Kutner, C.M. Rogers, M.F. Lubin, G.A. Fleming, and R.P. Bain Impaired growth hormone secretion in the adult population: relation to age and adiposity J. Clin. Invest. 67 1981 1361 1369
90. S.J. Russell, and C.R. Kahn Endocrine regulation of ageing Nat. Rev. Mol. Cell Biol. 8 2007 681 691
91. M.S. Sandhu, A.H. Heald, J.M. Gibson, J.K. Cruickshank, D.B. Dunger, and N.J. Wareham Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study Lancet 359 2002 1740 1745
92. S. Saydah, B. Graubard, R. Ballard-Barbash, and D. Berrigan Insulin-like growth factors and subsequent risk of mortality in the United States Am. J. Epidemiol. 166 2007 518 526
93. W.E. Sonntag, M. Ramsey, and C.S. Carter Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging Ageing Res. Rev. 4 2005 195 212
94. R. Steuerman, O. Shevah, and Z. Laron Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies Eur. J. Endocrinol. 164 2011 485 489
95. C.E. Stewart, and P. Rotwein Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors Physiol. Rev. 76 1996 1005 1026
96. Y. Suh, G. Atzmon, M.O. Cho, D. Hwang, B. Liu, D.J. Leahy, N. Barzilai, and P. Cohen Functionally significant insulin-like growth factor I receptor mutations in centenarians Proc. Natl. Acad. Sci. USA 105 2008 3438 3442
97. L.Y. Sun, K. Al-Regaiey, M.M. Masternak, J. Wang, and A. Bartke Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice Neurobiol. Aging 26 2005 929 937
98. E.G. Sustarsic, R.K. Junnila, and J.J. Kopchick Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment Biochem. Biophys. Res. Commun. 441 2013 144 150
99. J. Svensson, D. Carlzon, M. Petzold, M.K. Karlsson, Ö. Ljunggren, A. Tivesten, D. Mellström, and C. Ohlsson Both low and high serum IGF-I levels associate with cancer mortality in older men J. Clin. Endocrinol. Metab. 97 2012 4623 4630
100. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96
101. C. Tazearslan, J. Huang, N. Barzilai, and Y. Suh Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles Aging Cell 10 2011 551 554
102. P. Toth, S. Tarantini, N.M. Ashpole, Z. Tucsek, G.L. Milne, N.M. Valcarcel-Ares, A. Menyhart, E. Farkas, W.E. Sonntag, A. Csiszar, and Z. Ungvari IGF-1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging Aging Cell 14 2015 1034 1044
103. S. Tumati, H. Burger, S. Martens, Y.T. van der Schouw, and A. Aleman Association between Cognition and Serum Insulin-Like Growth Factor-1 in Middle-Aged & Older Men: An 8 Year Follow-Up Study PLoS ONE 11 2016 e0154450
104. Z. Ungvari, and A. Csiszar The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 599 610
105. C.C. van Bunderen, I.C. van Nieuwpoort, N.M. van Schoor, D.J. Deeg, P. Lips, and M.L. Drent The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study J. Clin. Endocrinol. Metab. 95 2010 4616 4624
106. E. van der Spoel, M.P. Rozing, J.J. Houwing-Duistermaat, P.E. Slagboom, M. Beekman, A.J. de Craen, R.G. Westendorp, and D. van Heemst Association analysis of insulin-like growth factor-1 axis parameters with survival and functional status in nonagenarians of the Leiden Longevity Study Aging (Albany, N.Y.) 7 2015 956 963
107. D. van Heemst, M. Beekman, S.P. Mooijaart, B.T. Heijmans, B.W. Brandt, B.J. Zwaan, P.E. Slagboom, and R.G. Westendorp Reduced insulin/IGF-1 signalling and human longevity Aging Cell 4 2005 79 85
108. N.C. van Varsseveld, E. Sohl, M.L. Drent, and P. Lips Gender-Specific Associations of Serum Insulin-Like Growth Factor-1 With Bone Health and Fractures in Older Persons J. Clin. Endocrinol. Metab. 100 2015 4272 4281
109. R.S. Vasan, L.M. Sullivan, R.B. D'Agostino, R. Roubenoff, T. Harris, D.B. Sawyer, D. Levy, and P.W. Wilson Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study Ann. Intern. Med. 139 2003 642 648
110. M. Wang, and R.A. Miller Fibroblasts from long-lived mutant mice exhibit increased autophagy and lower TOR activity after nutrient deprivation or oxidative stress Aging Cell 11 2012 668 674
111. Y. Wang, T. Sakata, H.Z. Elalieh, S.J. Munson, A. Burghardt, S. Majumdar, B.P. Halloran, and D.D. Bikle Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I J. Endocrinol. 189 2006 279 287
112. A.J. Westwood, A. Beiser, C. Decarli, T.B. Harris, T.C. Chen, X.M. He, R. Roubenoff, A. Pikula, R. Au, L.E. Braverman, and et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy Neurology 82 2014 1613 1619
113. Y. Wu, H. Sun, J. Basta-Pljakic, L. Cardoso, O.D. Kennedy, H. Jasper, H. Domené, L. Karabatas, C. Guida, M.B. Schaffler, and et al. Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor J. Bone Miner. Res. 28 2013 1575 1586
114. J. Xu, G. Gontier, Z. Chaker, P. Lacube, J. Dupont, and M. Holzenberger Longevity effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor activation Aging Cell 13 2014 19 28
115. T. Yamaguchi, M. Kanatani, M. Yamauchi, H. Kaji, T. Sugishita, D.J. Baylink, S. Mohan, K. Chihara, and T. Sugimoto Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women Calcif. Tissue Int. 78 2006 18 24
116. H. Yamamoto, M. Sohmiya, N. Oka, and Y. Kato Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults Acta Endocrinol. 124 1991 497 500
117. N.Y. Yuldasheva, S.T. Rashid, N.J. Haywood, P. Cordell, R. Mughal, H. Viswambharan, H. Imrie, P. Sukumar, R.M. Cubbon, A. Aziz, and et al. Haploinsufficiency of the insulin-like growth factor-1 receptor enhances endothelial repair and favorably modifies angiogenic progenitor cell phenotype Arterioscler. Thromb. Vasc. Biol. 34 2014 2051 2058